Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06158841

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham - Main /ID# 261434 Birmingham, Alabama, United States
  • Mayo Clinic Hospital - Phoenix /ID# 263326 Phoenix, Arizona, United States
  • Alta Bates Summit Medical Center for Research /ID# 261438 Berkeley, California, United States
  • Providence - St. Jude Medical Center /ID# 262031 Fullerton, California, United States
View all 166 locations
View Trial Details
Active, not recruiting

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

NCT06456346

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Palo Verde Cancer Specialists ( Site 0052) Glendale, Arizona, United States
  • Los Angeles Cancer Network ( Site 0025) Glendale, California, United States
  • Stanford Cancer Center ( Site 0024) Palo Alto, California, United States
  • Exempla Lutheran Medical Center ( Site 0014) Golden, Colorado, United States
View all 171 locations
View Trial Details
Active, not recruiting

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

NCT04464200

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)

NCT05490446

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • Innovative Clinical Research Institute Whittier Lakewood, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Emad Ibrahim, MD, Inc. Redlands, California, United States
  • Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
View all 45 locations
View Trial Details

Related conditions